SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
SocialPicks Community
MRK
MRK
|
|
|
DRUGS IN PROPER TIME ARE GOOD
|
FDA Calendar Updates: Anadys, Merck, Schering-Plough
MRK
|
|
|
Below is a summary of updates to the BioMedReports.com FDA Calendar , which includes a database of 289 entries as of 7/30/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of BioMedReports.com, the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pending late-stage clinical trial results. ...
|
FDA Calendar, Extreme Trade Updates: CXM, ELRN, SGP, Shire
MRK
|
|
|
<> Below is a summary of updates to the <font> BioMedReports.com FDA Calendar </font> , which includes a database of 284 entries as of 7/28/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of BioMedReports.com, the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pending late-stage clinical...
|
Merck & Co. Inc.
MRK
|
|
|
7. Merck‘s (MRK) shares can be moved by patent expirations, generic competition, FDA announcements of drug side-effects, and its acquisition of Schering-Plough. Its stock is also subject to trading based on news from the Big Pharma and biotech industries and the Administration’s new healthcare plans. Merck is the sixth most shorted stock among all companies listed on the NYSE. There are 164 million shares short in the company and daily trading volume is almost 20 million shares. Merck’s stock has been as high as $31 this year and as low as $20.
|
FDA Calendar Updates: BVX, HEB, HGSI, ONXX, SGP
MRK
|
|
|
<> Below is a summary of updates to the <font> BioMedReports.com FDA Calendar </font> , which includes a database of 273 entries as of 7/22/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of <font> BioMedReports.com </font> , the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pendin...
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
Visit streetinsider.com
Portfolio results thru 8/8/08
- Portfolio at www.updown.com - started 1/11/08
9.8% return includes dividends and commission.
Started socialpicks on 6/30. some stocks here are not in...
|
Stock update and watch list 7/29/08
- Due to difficulties understanding the socialpicks system regarding changing rating from buy to hold and thus resetting the performance, I wanted to sum...
|
More Resources
|
About Merck & Co Inc
- Answers.com
